Hypercalcaemia Severity Classifier

Grade a hypercalcaemia on albumin-corrected calcium in mmol/L and mg/dL, with both published band sets attributed — because they disagree between 3.4 and 3.5 — and with the clinical state and the PTH branch built in.

The two published band sets, and where they disagree

mmol/L and mg/dL are not interchangeable at the round numbers

The first branch: PTH-driven or PTH-independent

Correct it first, then grade it — and grade it against both published scales

Grading a hypercalcaemia has three steps that are routinely collapsed into one, and collapsing them is where the errors come from. The first is the correction. About 40% of total serum calcium is bound to albumin and takes no part in the ionised fraction that tissues respond to, so a fall in albumin lowers the measured total calcium without changing the physiology. In a hypoalbuminaemic patient — which describes a large proportion of the people in whom a calcium is checked urgently — an uncorrected total calcium understates the true level, and a real hypercalcaemia can be entirely hidden by a low albumin. The correction has to happen before the classification, not after it. The site’s albumin-corrected calcium calculator does the adjustment and sets out the evidence against relying on it in critical illness, chronic kidney disease and after major surgery, where the formulas over- and under-correct unpredictably. Where the answer will change management, measure an ionised calcium: only the ionised fraction is metabolically active, no correction formula appears to be totally accurate, and a measured ionised calcium remains the benchmark.

The second step is the grading itself, and there are two published band sets rather than one. The Endocrine Society’s guideline on hypercalcaemia of malignancy defines mild as an albumin-adjusted calcium below 12 mg/dL (under 3 mmol/L), moderate as 12 to 14 mg/dL (3 to 3.5 mmol/L) and severe as above 14 mg/dL (over 3.5 mmol/L). UK guidance — the North Bristol primary care guideline and the Kent and Medway network document among others — uses mild 2.6 to 3.0, moderate 3.0 to 3.4 and severe above 3.4 mmol/L. The figures most often quoted in British practice are the second set, and they are not the Endocrine Society’s. The two agree up to 3.4 mmol/L and disagree above it: 3.4 to 3.5 mmol/L is severe to one and moderate to the other. That band gets its own verdict on this page rather than being assigned silently to whichever scale the author happened to prefer.

Underneath the disagreement there is a units problem worth naming. Calcium’s atomic weight is 40.078, so one millimole per litre is 4.0078 mg/dL. That makes 3.0 mmol/L equal to 12.02 mg/dL, 3.4 mmol/L equal to 13.63, and 14 mg/dL equal to 3.49 mmol/L. Guidelines pair 12 to 14 mg/dL with 3 to 3.5 mmol/L as though the two were identical, and they are close but rounded; the UK’s 3.4 mmol/L severe threshold is about 0.4 mg/dL below the Endocrine Society’s. Watch for mEq/L on older reports as well, because calcium is divalent and mEq/L is twice mmol/L — reading one as the other doubles the result.

The third step is the one no table contains: severity is clinical as much as it is numeric. The published account of the syndrome is explicit that patients tolerate higher serum calcium levels more readily if the onset is relatively gradual, and contrasts an acute, severe presentation with a chronic and relatively mild one at similar levels. A calcium that has risen from 2.5 to 3.0 over a fortnight in someone who is now drowsy and vomiting is a more urgent problem than a stable 3.2 in someone who has had it for two years and feels much as usual. That is why the clinical-state question on this page sits above the numeric bands in the logic rather than beneath them, and why the single most useful piece of information in a hypercalcaemia is a previous calcium result. The mechanism explains the pattern: hypercalcaemia causes a nephrogenic diabetes insipidus, the resulting dehydration concentrates the calcium further, and the two drive each other — which is also why intravenous isotonic saline is the first treatment for nearly everyone who is unwell with it, and often the only one needed acutely.

After the grading, one test does most of the diagnostic work. A normal parathyroid gland suppresses in response to a high calcium, so a PTH that is raised — or merely sitting inside a reference interval derived from people with normal calcium, which in this context is inappropriately normal — means PTH-mediated disease: primary hyperparathyroidism most often, or tertiary hyperparathyroidism, familial hypocalciuric hypercalcaemia, lithium or a thiazide. A suppressed PTH means the drive is coming from elsewhere, and malignancy heads that list, acting through parathyroid hormone-related peptide, osteolytic metastases or tumour production of 1,25-dihydroxyvitamin D in lymphoma. Those two halves share almost no further investigation, which is why the PTH goes with the confirmatory calcium rather than after it. The site’s PTH unit converter handles pmol/L against pg/mL, the calcium:creatinine clearance ratio separates primary hyperparathyroidism from familial hypocalciuric hypercalcaemia, the vitamin D status interpreter places the 25-hydroxyvitamin D that both of those depend on, and the calcium unit converter handles mmol/L, mg/dL and mEq/L.

Frequently asked questions

Related calculators

References

1. El-Hajj Fuleihan G, Clines GA, Hu MI, et al. Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(3):507–528 — mild as an albumin-adjusted calcium under 12 mg/dL (3.5 mmol/L), and the suggestion of calcitonin with an intravenous bisphosphonate or denosumab in severe disease with calcitonin limited to 48 to 72 hours.
2. Hypercalcemia. In: Endotext. South Dartmouth (MA): MDText.com (NBK279037) — that only the ionised calcium is metabolically active and that no correction formula appears to be totally accurate with a measured ionised calcium remaining the benchmark; that above 14 mg/dL (3.5 mM) most patients are symptomatic; that above 12 mg/dL (3 mM) prompts urgent management and below 12 mg/dL without symptoms the underlying disorder is what is treated; the PTH-mediated versus non-PTH-mediated branch; and that patients tolerate higher levels more readily when the onset is gradual.
3. North Bristol NHS Trust. Hypercalcaemia Guideline for Primary Care — mild 2.6 to 3.0 mmol/L, moderate 3.0 to 3.4, severe above 3.4, an upper limit of normal of 2.6 mmol/L, and the PTH-directed pathways including the urine calcium excretion index.
4. Kent and Medway Cancer Collaborative. Hypercalcaemia Guidelines, version 5 — mild 2.65 to 3.00 mmol/L, moderate 3.01 to 3.40 and severe above 3.40 mmol/L.
5. International Union of Pure and Applied Chemistry. Standard atomic weight of calcium, 40.078 — the basis for the mmol/L to mg/dL factor of 4.0078 used throughout this page.

Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.